A citation-based method for searching scientific literature

Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs, Taia T Wang, Robert E Schwartz, Jean K Lim, Randy A Albrecht, Benjamin R tenOever. Cell 2020
Times Cited: 1481



Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang, Dai-Shi Tian. Clin Infect Dis 2020
Times Cited: 2017




List of shared articles



Times cited

Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Roshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, Cesar M Rueda, Amber Gibbs, Will Guider, Claire Stewart, Sergio D Rosenzweig, Huanyu Wang, Sophonie Jean,[...]. J Allergy Clin Immunol 2021
5


Cytokine profile and disease severity in patients with COVID-19.
Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi. Cytokine 2021
23

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.
Luca Perico, Ariela Benigni, Federica Casiraghi, Lisa F P Ng, Laurent Renia, Giuseppe Remuzzi. Nat Rev Nephrol 2021
101

The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.
Ayse Basak Engin, Evren Doruk Engin, Atilla Engin. Environ Toxicol Pharmacol 2021
7

Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19.
Pierre Kory, G Umberto Meduri, Jose Iglesias, Joseph Varon, Paul E Marik. J Intensive Care Med 2021
9

Illuminating the immunopathology of SARS-CoV-2.
Suraj Saksena, Pratip Chattopadhyay. Cytometry B Clin Cytom 2021
6

Rationale for azithromycin in COVID-19: an overview of existing evidence.
Iwein Gyselinck, Wim Janssens, Peter Verhamme, Robin Vos. BMJ Open Respir Res 2021
6

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Angela Wahl, Lisa E Gralinski, Claire E Johnson, Wenbo Yao, Martina Kovarova, Kenneth H Dinnon, Hongwei Liu, Victoria J Madden, Halina M Krzystek, Chandrav De,[...]. Nature 2021
42

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Alexander Huang, Erin Bange, Nicholas Han, E Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson, Allison Greenplate, Florence Porterfield, Olutosin Owoyemi,[...]. Res Sq 2021
12


SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, Tiansheng Zhong, Hao Tang, Wei Du, Luying Wang,[...]. Cell Rep 2021
27


Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
Daisy A Hoagland, Rasmus Møller, Skyler A Uhl, Kohei Oishi, Justin Frere, Ilona Golynker, Shu Horiuchi, Maryline Panis, Daniel Blanco-Melo, David Sachs,[...]. Immunity 2021
40

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes.
Thais Fernanda de Campos Fraga-Silva, Sandra Regina Maruyama, Carlos Arterio Sorgi, Elisa Maria de Sousa Russo, Ana Paula Morais Fernandes, Cristina Ribeiro de Barros Cardoso, Lucia Helena Faccioli, Marcelo Dias-Baruffi, Vânia Luiza Deperon Bonato. Front Immunol 2021
3

COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
Bing Xie, Jiancheng Zhang, Yuwen Li, Shiying Yuan, You Shang. Front Immunol 2021
4